⌘K

Login Start Free

Home/Filings/4/0001209191-23-047521

4//SEC Filing

Hayes Christopher G. 4

Accession 0001209191-23-047521

CIK 0001660334other

View on SEC.gov Company Profile

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 4:39 PM ET

Size

4.9 KB

Accession

0001209191-23-047521

Insider Transaction Report

Form 4

Period: 2023-08-24

Verrica Pharmaceuticals Inc.VRCA

Hayes Christopher G.

CHIEF LEGAL OFFICER

Transactions

Award
Common Stock
2023-08-24+75,000→ 156,925 total

Footnotes (1)

[F1]Represents vesting of shares of common stock underlying performance stock units resulting from the achievement of certain non-financial milestones. These shares have not been delivered.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Verrica Pharmaceuticals Inc.

CIK 0001660334

Entity typeother

Related Parties

1

filerCIK 0001805359

Filing Metadata

Form type: 4
Filed: Aug 27, 8:00 PM ET
Accepted: Aug 28, 4:39 PM ET
Size: 4.9 KB

View on SEC.gov